EMBO is an international organization that promotes excellence in the life sciences. EMBO’s main tasks:
- to support scientists at different stages of their careers
- to fund scientific courses and workshops
- to publish scientific journals
- to contribute to shaping science and research policy in Europe.
A major goal of EMBO is to create an environment where scientists can work according to the highest scientific standards and principles of research integrity.
EMBO has been pursuing high quality, responsible research and robust and open goals at all levels for over 50 years in its training and education of early career researchers, its scientific publication process, and through creating new tools for sharing scientific data, promoting scientific integrity, and exploring innovative scientific policies.
Investigation
EMBO has its own procedures to evaluate allegations of research misconduct by its members, grantees and awardees. Allegations from any source, including from anonymous individuals or administrative officials in institutions, are first considered by the EMBO Director.
Well-founded allegations are evaluated by an ad hoc committee, composed of EMBO Members and assisted by EMBO staff. Not having direct access to data and other information held at researchers’ institutes, EMBO bases its evaluations on the information received in grant and award applications and membership nominations, and publicly available information. When research misconduct is found, possible sanctions by EMBO include withdrawal of funding or support and revoking of awards.
Training
EMBO holds Research Integrity workshops at research institutions in EMBC Member States covering conflicts of interest, ethical practices in human and animal research, scientific publication, emerging policy issues in data management, and mentoring. The workshops are highly interactive and include discussions of scenarios. They are targeted at senior post-docs and early PIs in the life sciences and are held 4 or 5 times per year. As of now, they have taken place in 15 countries with over 400 participants.
To give some examples of their impact, as a result of such workshops, the Curie Institute in Paris instituted compulsory training in research integrity issues for young group leaders; the Institute for Biotechnology, Helsinki, set up a committee to produce a code of conduct for mentorship; and the Instituto de Investigação e Inovação em Saúde, Porto, set up a working group to develop authorship guidelines.
For more information: www.embo.org/policy/research-integrity/workshops-on-research-integrity/
Promoting Research Integrity
Promoting research quality and scientific integrity are core principles of EMBO, which permeate all its initiatives from the training of the next generation of scientists to communicating research outcomes. The policies and tools developed by EMBO are shared freely and have established new standards and practices for the scientific community.
The practical application of concepts of responsible conduct of research have been a major concern of EMBO since its founding. EMBO was instrumental in driving discussions about societal concerns on recombinant DNA at the 1975 Asilomar meeting, and supported a workshop on DNA restriction and modification in Basel in 1972.
EMBO has been among the sponsors of the World Conferences on Research Integrity since the first event in 2007, and was one of the first funders in Europe to require training in RI (using a programme developed in part by EMBO and other research institutions) as a condition to receive funding in its Fellowship and Young Investigator schemes. To date over 1,200 EMBO awardees have completed this training.
Promoting research quality and scientific integrity are core principles of EMBO, which permeate all its initiatives from the training of the next generation of scientists to communicating research outcomes. The policies and tools developed by EMBO are shared freely and have established new standards and practices for the scientific community.
The practical application of concepts of responsible conduct of research have been a major concern of EMBO since its founding. EMBO was instrumental in driving discussions about societal concerns on recombinant DNA at the 1975 Asilomar meeting, and supported a workshop on DNA restriction and modification in Basel in 1972.
EMBO has been among the sponsors of the World Conferences on Research Integrity since the first event in 2007, and was one of the first funders in Europe to require training in RI (using a programme developed in part by EMBO and other research institutions) as a condition to receive funding in its Fellowship and Young Investigator schemes. To date over 1,200 EMBO awardees have completed this training.
EMBO develops innovative approaches to the promotion of research integrity, quality research, and open science. A recent example is the “Governance of Research Integrity” project, which investigated options for an integrated approach in Europe as an alternative to the existing patchwork of national and institutional regulations. The final report explores possibilities from the creation of a dedicated new European body to a range of options for coordinating the activities of existing entities. The project involved multiple stakeholders from academia, the private sector, and government, and included a workshop organized with the OECD’s Global Science Forum. For more information: https://www.embo.org/documents/science_policy/governance_of_ri.pdf
EMBO has also researched the thorny issue of peer review for funding allocation. Information for decision-makers was published in March 2021 year in a report entitled “Dealing with the limits of peer review with innovative approaches to allocating research funding”. The report describes selection mechanisms including lotteries, equal distribution of funds, and traditional metric-based evaluation systems. These reports exemplify EMBO’s commitment to analysing real-world outcomes of science policies and the generation of innovative solutions. For more information: https://www.embo.org/documents/science_policy/peer_review_report.pdf
EMBO is one of the founding organisations of the 2013 San Francisco Declaration on Research Assessment (DORA, https://sfdora.org). DORA signatories commit to the assessment of research on its own merits, halting the pernicious use of bibliometric indicators, in particular the Journal Impact Factor (JIF), as surrogates to judge the quality of research and researchers. EMBO has implemented DORA principles: by 2014, EMBO had modified its instructions to both reviewers and applicants to EMBO fellowships and grants to abandon the use of the JIF. Instead, EMBO asks applicants and nominators to provide key references and a description of their major scientific contributions.
|